Setterwalls has advised SynAct Pharma AB.SynAct Pharma AB announced the listing of the company’s shares on Nasdaq Stockholm, Mid Cap. The trading on Nasdaq Stockholm commenced on…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
